## Abstract Pancreatic cancer is a devastating disease with a poor prognosis for most patients. Surgical resection remains the cornerstone of treatment, providing the only realistic hope of longβterm survival. Even with optimal surgical management, 5βyear survival averages 15% to 20% for resectable
Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer
β Scribed by Alessandro Zerbi; Vittorio Fossati; Danilo Parolini; Michele Carlucci; Gianpaolo Balzano; Giovanni Bordogna; Carlo Staudacher; Valerio Di Carlo
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 521 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The purpose of this study is to review the role of radiation therapy in the treatment of resectable rectal adenocarcinoma. Selection criteria, treatment techniques, and results are discussed. J. Surg. Oncol. 2002;79:107β117. Β© 2002 WileyβLiss, Inc.
The outcome of patients with rectal cancer treated by abdominoperineal or anterior resection, with or without preoperative radiotherapy, was assessed to detect any differences attributable to the operative method and interactions between radiotherapy and type of surgery. The study was based on 1292
## Abstract ## BACKGROUND: The benefit of adjuvant radiotherapy (RT) for resected pancreatic adenocarcinoma remains controversial after randomized clinical trials. In this nationalβlevel US study, a propensity score (conditional probability of receiving RT) was used to adjust for potential confoun